These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12937119)

  • 21. [Guillain-Barre syndrome in children in 2009-2014 years].
    Stasiak K; Wesołowska E; Kroczka S
    Przegl Lek; 2016; 73(3):167-9. PubMed ID: 27349047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversible posterior leukoencephalopathy, cerebral vasoconstriction, and strokes after intravenous immune globulin therapy in guillain-barre syndrome.
    Doss-Esper CE; Singhal AB; Smith MS; Henderson GV
    J Neuroimaging; 2005 Apr; 15(2):188-92. PubMed ID: 15746232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single high-dose immunoglobulin therapy for childhood Guillain-Barré syndrome.
    Zafeiriou DI; Kontopoulos EE; Katzos GS; Gombakis NP; Kanakoudi FG
    J Child Neurol; 1999 Jul; 14(7):480-1. PubMed ID: 10573477
    [No Abstract]   [Full Text] [Related]  

  • 24. Understanding Guillain-Barré syndrome.
    Estridge R; Iskander M
    JAAPA; 2015 Jul; 28(7):19-22. PubMed ID: 26075345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intensive therapy for patients with Guillian-Barré syndrome].
    Buus L; Tønnesen EK
    Ugeskr Laeger; 2014 Oct; 176(42):. PubMed ID: 25316360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive serological tests for syphilis and administration of intravenous immunoglobulin.
    Constable SA; Parry CM; Enevoldson TP; Bradley M
    Sex Transm Infect; 2007 Feb; 83(1):57-8. PubMed ID: 17283361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guillain-Barre syndrome in a 7-month-old boy successfully applied plasma exchange.
    Akarcan SE; İşgüder R; Yılmaz Ü; Ayhan Y; Ceylan G; Ağın H
    Transfus Apher Sci; 2016 Feb; 54(1):139-43. PubMed ID: 26803348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Eczematous reactions after intravenous immunoglobulin therapy in two patients with Guillain-Barré syndrome and a patient with Miller Fisher syndrome].
    Tada M; Tada M; Ishiguro H; Yagi E; Hirota K
    No To Shinkei; 2003 May; 55(5):401-5. PubMed ID: 12833881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guillain-barré syndrome in pregnancy: early diagnosis and treatment is essential for a favorable outcome.
    Campos da Silva F; de Moraes Paula G; Dos Santos Esteves Automari CV; Mendes de Almeida DS; Ubirajara Cavalcanti Guimarães R
    Gynecol Obstet Invest; 2009; 67(4):236-7. PubMed ID: 19293590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is a second cycle of immunoglobulin justified in axonal forms of Guillain-Barré syndrome?
    Godoy DA; Rabinstein A
    Arq Neuropsiquiatr; 2015 Oct; 73(10):848-51. PubMed ID: 26465402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of immunomodulation therapies in mechanically ventilated patients with Guillain Barré syndrome.
    Netto AB; Kulkarni GB; Taly AB; Rao GU; Periyavan S; Rao S
    J Clin Neurosci; 2012 Dec; 19(12):1664-7. PubMed ID: 23036171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous immunoglobulin treatment in children with Guillain-Barré syndrome.
    Korinthenberg R
    Eur J Paediatr Neurol; 1998; 2(1):57-9. PubMed ID: 10726847
    [No Abstract]   [Full Text] [Related]  

  • 33. Human immunoglobulin and the Guillain-Barre syndrome: new indication. An alternative to plasmapheresis.
    Prescrire Int; 2000 Oct; 9(49):142-3. PubMed ID: 11603414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of Guillain-Barré Syndrome].
    Nomura K
    Brain Nerve; 2015 Nov; 67(11):1397-410. PubMed ID: 26560955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Guillain-Barré syndrome with central nervous system symptoms. Report of two cases].
    Łabuz-Roszak B; Pierzchała K; Kapustecki J; Biernawska J; Mańka I; Kumor K
    Neurol Neurochir Pol; 2004; 38(3):221-6. PubMed ID: 15354236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and cost effectiveness of current therapies in Guillain Barre syndrome.
    Mehndiratta MM; Chowdhury D; Goel V
    J Assoc Physicians India; 2001 Apr; 49():459-69. PubMed ID: 11762620
    [No Abstract]   [Full Text] [Related]  

  • 37. A case of Guillain-Barré syndrome with meningeal irritation.
    Ashikari Y; Kobayashi S; Tago A; Yoneyama M; Ito M; Fukuda K; Mizuno Y; Tsunoda Y; Shimizu S; Yokoi K; Kamioka N; Hamajima N; Suzuki S
    Brain Dev; 2016 Jan; 38(1):163-6. PubMed ID: 26403311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neonatal-Onset Recurrent Guillain-Barré Syndrome-Like Disease: Clues for Inherited CD59 Deficiency.
    Ardicli D; Taskiran EZ; Kosukcu C; Temucin C; Oguz KK; Haliloglu G; Alikasifoglu M; Topaloglu H
    Neuropediatrics; 2017 Dec; 48(6):477-481. PubMed ID: 28800659
    [No Abstract]   [Full Text] [Related]  

  • 39. Guillain-Barré syndrome.
    Ansar V; Valadi N
    Prim Care; 2015 Jun; 42(2):189-93. PubMed ID: 25979580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous immunoglobulin treatment in children with Guillain-Barre syndrome.
    Gürses N; Uysal S; Cetinkaya F; Işlek I; Kalayci AG
    Scand J Infect Dis; 1995; 27(3):241-3. PubMed ID: 8539548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.